[HTML][HTML] Risk factors for the development of the disease in antiphospholipid antibodies carriers: a long-term follow-up study

RD Pablo, PM Cacho, M López-Hoyos… - Clinical Reviews in …, 2022 - Springer
The natural history of antiphospholipid antibodies (aPL) carriers is not well-established. The
objectives of the present study were (a) to study the probability of developing clinical criteria …

Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study

PR Demetrio, PM Cacho, LH Marcos… - Clinical Reviews in …, 2022 - search.proquest.com
The natural history of antiphospholipid antibodies (aPL) carriers is not well-established. The
objectives of the present study were (a) to study the probability of developing clinical criteria …

[HTML][HTML] Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study

RD Pablo, PM Cacho, M López-Hoyos… - Clinical Reviews in …, 2022 - ncbi.nlm.nih.gov
The natural history of antiphospholipid antibodies (aPL) carriers is not well-established. The
objectives of the present study were (a) to study the probability of developing clinical criteria …

Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.

RD Pablo, PM Cacho, M López-Hoyos… - Clinical Reviews in …, 2021 - europepmc.org
The natural history of antiphospholipid antibodies (aPL) carriers is not well-established. The
objectives of the present study were (a) to study the probability of developing clinical criteria …

Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study

RD Pablo, PM Cacho… - Clinical reviews in …, 2022 - pubmed.ncbi.nlm.nih.gov
The natural history of antiphospholipid antibodies (aPL) carriers is not well-established. The
objectives of the present study were (a) to study the probability of developing clinical criteria …